Log in

Relevant bibliographies by topics / HYPERTENSIVE DRUGS / Books

Books on the topic 'HYPERTENSIVE DRUGS'

To see the other types of publications on this topic, follow the link: HYPERTENSIVE DRUGS.

Author: Grafiati

Published: 11 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'HYPERTENSIVE DRUGS.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Heart attacks, hypertension, and heart drugs. Emmaus, Pa: Rodale Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

M, Drayer Jan I., Lowenthal David T, and Weber Michael A, eds. Drug therapy in hypertension. New York: Dekker, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Switzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension: International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Darmstadt: Steinkopff, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

1947-, Martin John E., and Dubbert Patricia M, eds. Non-drug treatments for essential hypertension. New York: Pergamon Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

H, Messerli Franz, and Opie Lionel H, eds. Combination drug therapy for hypertension. New York: Author's Pub. House, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mann, Samuel J. Hypertension and you: Old drugs, new drugs, and the right drugs for your high blood pressure. Lanham: Rowman & Littlefield Publishers, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

van, Zwieten P. A., and Greenlee William J, eds. Antihypertensive drugs. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

H, Messerli Franz, ed. The Heart and hypertension. New York, N.Y: Yorke Medical Books, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bönner, Gerd. Prostacyclin and hypertension. Berlin: Springer-Verlag, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lower blood pressure without drugs: Curing your hypertension naturally. 2nd ed. Garden City Park, NY: Square One Publishers, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Parsont, Wolfson Rita, ed. How to control high blood pressure without drugs. New York: Scribner, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Walter, Flamenbaum, and Punzi Henry A, eds. Hypertension. Mount Kisco, NY: Futura Pub. Co., 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Richard, Trubo, ed. The H.A.R.T. program: Lower your blood pressure without drugs. New York, N.Y: HarperCollins Publishers, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Burnier, Michel, ed. Drug Adherence in Hypertension and Cardiovascular Protection. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76593-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Toma, Strasser, Ganten D. 1941-, World Health Organization, and International Society of Hypertension, eds. Mild hypertension: From drug trials to practice. New York: Raven Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Handbook of hypertension. Chichester, West Sussex: Wiley-Blackwell, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Masaru, Minami, Parvez H, and Saitō Hideya 1933-, eds. Antihypertensive drugs today. Utrecht, The Netherlands: VSP, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

The DASH diet for hypertension: Lower your blood pressure in 14 days-- without drugs. New York: Gallery Books, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Moore, Thomas J., M.D., ed. The DASH diet for hypertension: Lower your blood pressure in 14 days--without drugs. New York: Pocket Books, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Arteries in clinical hypertension. Philadelphia: J.B. Lippinott, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Safar, Michel. Arteries in clinical hypertension. Philadelphia: Lippincott-Raven, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

K, Hollenberg Norman, ed. Hypertension: Mechanisms and therapy. Philadelphia: Current Medicine, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

NHS Centre for Reviews & Dissemination., ed. Drug treatment of essential hypertension in older people. York: NHS Centre for Reviews and Dissemination, University of York, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Clinical management of hypertension. 6th ed. Caddo, OK: Professonal Communications, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Parsont, Wolfson Rita, ed. How to control high blood pressure without drugs. New York: Ivy Books/Ballantine, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

1937-, Epstein Murray, and Loutzenhiser Rodger, eds. Calcium antagonists and the kidney. Philadelphia, PA: Hanley & Belfus, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Simons, David R. Hypertension: A physician's guide to drug selection and use. Boulder, Colo. (1550 Baseline Rd., Boulder 80302): Keyed Reviews Publications, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

L, Prisant Michael, ed. Hypertension in the elderly. Totowa, N.J: Humana Press, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Canadian Hypertension Society Consensus Conference (1993), ed. Guidelines for the treatment of uncomplicated hypertension. Toronto, Canada: Queen's Printer for Ontario, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Nordmann, Alain Joel. Cost-effectiveness of routine echocardiography in hypertensive patients starting antihypertensive drug therapy. Ottawa: National Library of Canada, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Igakubu, Hokkaidō Daigaku, ed. New advances in antihypertensive drug research: Pathophysiology and pharmacology. Sapporo, Japan: Hokkaido University School of Medicine, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

1933-, Aoki K., and Frohlich Edward D. 1931-, eds. Calcium in essential hypertension. Tokyo: Academic Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Hypertension and dyslipidemia management essentials. Sudbury, Mass: Physicians' Press/Jones and Bartlett Publishers, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

1938-, Bennett William M., and McCarron David A, eds. Pharmacology and management of hypertension. New York: Churchill Livingstone, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

B, Puschett Jules, and Greenberg Arthur 1950-, eds. Diuretics IV: Chemistry, pharmacology, and clinical applications : proceedings of the Fourth International Conference on Diuretics, Boca Raton, Florida, U.S.A., 11-16 October 1992. Amsterdam: Excerpta Medica, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

1942-, Black Henry R., ed. Clinical trials in hypertension. New York: Marcel Dekker, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

1938-, Bennett William M., and McCarron David A, eds. Pharmacotherapy of renal disease and hypertension. New York: Churchill Livingstone, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

J, Horan Michael, Page Lot B, National Institutes of Health (U.S.), and Workshop on Drug Side Effects, Drug-Drug Interactions, Drug Resistance, and Patient Compliance in the Management of Hypertension (1986 : Bethesda, Md.), eds. Drug side effects, drug-drug interactions, drug resistance and patient compliance in the management of hypertension: Bethesda, Maryland, April 28-29 1986. [Dallas, Tex.]: American Heart Association, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hypertension management for the primary care clinician. Bethesda, Md: American Society of Health-System Pharmacists, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Guthrie, Robert M. Pharmacological management of hypertension and dyslipidemia. Sudbury, Mass: Jones and Bartlett Publishers, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

1958-, Böhm M., and Laragh John H. 1924-, eds. From hypertension to heart failure. Berlin: Springer, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Nederfors, Tommy. Xerostomia: Prevalence and pharmacotherapy : with special reference to -adrenoceptor antagonists. [Halmstad]: [Göteborg Univ.], 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zuckerman, Ilene H. Identifying drug therapy inappropriateness: Determining the validity of drug use review screening criteria. Baltimore, Md: Center on Drugs and Public Policy, School of Pharmacy, University of Maryland at Baltimore, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

1933-, Aoki K., International Symposium on Mechanism and Treatment in Essential Hypertension (1st : 1985 : Nagoya-shi, Japan), and International Symposium on Rats with Spontaneous Hypertension and Related Studies (5th : 1985 : Kyoto, Japan), eds. Essential hypertension: Calcium mechanisms and treatment. Tokyo: Springer-Verlag, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gidwani, Hitesh, and Chenell Donadee. Hypertensive Emergencies (DRAFT). Edited by Raghavan Murugan and Joseph M. Darby. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190612474.003.0009.

Full text

Abstract:

Hypertensive emergencies may be encountered by rapid response teams (RRTs). Various forms of acute organ dysfunction separate hypertensive urgency from hypertensive emergency. These include acute heart failure, acute coronary syndrome, acute aortic dissection, ischemic stroke, hemorrhagic stroke, hypertensive encephalopathy, sympathetic crisis, postoperative hypertension, and hypertensive emergencies in pregnancy. RRTs must be able to rapidly assess the patient’s condition, initiate treatment, and triage the patient to the appropriate level of care. This chapter summarizes the initial evaluation and triage of the patient as well as the blood pressure reduction goals in the acute period for the various conditions associated with hypertensive emergencies, discussing suggested drugs with the dosages, and looking at common pitfalls.

APA, Harvard, Vancouver, ISO, and other styles

46

Wijdicks, Eelco F. M., and Sarah L. Clark. Antihypertensives and Antiarrhythmics. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0013.

Full text

Abstract:

Acute brain injury can precipitate a hypertensive response, which for the most part is the result of stress-induced, increased sympathetic activity. Acute stroke with hypertension may not be a response but more often a prior, untreated hypertension or a patient with no access to medication. This hypertensive response may wane quickly, and aggressive treatment of these temporary surges in blood pressure could have unwanted consequences. Important characteristics of most antihypertensive drugs used in the neurosciences intensive care unit are cost, having a rapid onset with a short duration of action, and having a low incidence of adverse side effects. Many of the antiarrhythmic drugs also have antihypertensive effects, so these drug classes are best combined in one chapter. This chapter discusses blood pressure targets, the most appropriate antihypertensive medications to use for acute management, and clinically relevant cardiac arrhythmias and their treatment.

APA, Harvard, Vancouver, ISO, and other styles

47

Paneni, Francesco, and Massimo Volpe. Co-morbidity (HFrEF and HFpEF): hypertension. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198784906.003.0415_update_001.

Full text

Abstract:

Hypertensive heart disease is a major cause of heart failure (HF) and mortality. Hypertension precedes HF occurrence in 75% of cases, and carries a sixfold increase in HF risk as compared to non-hypertensive individuals. Most importantly, a minority of patients survive 5 years after the onset of hypertensive HF. In hypertensive patients, the heart may present different patterns of adaptive remodelling: concentric remodelling, concentric hypertrophy, and eccentric hypertrophy. Although most hypertensive patients are at high risk of developing concentric hypertrophy, a growing proportion of subjects display a concentric-to-eccentric progression eventually leading to left ventricular dilation and systolic dysfunction. Several factors including myocardial ischaemia, ethnicity, genetic background, history of diabetes, and blood pressure pattern may significantly influence the pathway from hypertension to left ventricular dilation. Patients with a concentric hypertrophy usually develop HF with preserved ejection fraction (HFpEF), whereas those with an eccentric (dilated) phenotype develop HF with reduced ejection fraction (HFrEF). Lowering blood pressure has a striking effect in reducing the risk of HF. Although available antihypertensive drugs are all successful in lowering blood pressure, angiotensin-converting enzyme inhibitors, angiotensin receptor blocker (ARBs), and diuretics are more effective than other drug classes in preventing HF. The combination of the neprilysin inhibitor sacubitril with the ARB valsartan (LCZ696) has recently been shown to be highly effective in reducing HF-related outcomes in hypertensive subjects. An individualized treatment scheme taking into account blood pressure levels, type of HF (HFpEF or HFrEF), and relevant co-morbidities (i.e. renal disease, diabetes) is currently the best approach to improve morbidity and mortality in hypertensive patients with HF.

APA, Harvard, Vancouver, ISO, and other styles

48

Control High Blood Pressure Without Drugs: A Complete Hypertension Handbook. Fireside, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Groeneveld, A. B. J., and Alexandre Lima. Vasodilators in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0035.

Full text

Abstract:

Vasodilators are commonly used in the intensive care unit (ICU) to control arterial blood pressure, unload the left or the right heart, control pulmonary artery pressure, and improve microcirculatory blood flow. Vasodilator refers to drugs acting directly on the smooth muscles of peripheral vessel walls and drugs are usually classified based on their mechanism (acting directly or indirectly) or site of action (arterial or venous vasodilator). Drugs that have a predominant effect on resistance vessels are arterial dilators and drugs that primarily affect venous capacitance vessels are venous dilators. Drugs that interfere with sympathetic nervous system, block renin-angiotensin system, phosphodiesterase inhibitors, and nitrates are some examples of drugs with indirect effect. Vasodilator drugs play a major therapeutic role in hypertensive emergencies, primary and secondary pulmonary hypertension, acute left heart, and circulatory shock. This review discusses the main types of vasodilators drugs commonly used in the ICU.

APA, Harvard, Vancouver, ISO, and other styles

50

Hyper-Tension and You: Old Drugs, New Drugs and the Right Drugs for Your High Blood Pressure. Rowman & Littlefield Publishers, Incorporated, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!